To predict clinical applications, the in vitro analysis of iTreg polarization can provide insights into Treg function at the preclinical stage.
In this application note, we describe a means to robustly induce iTreg phenotypes from naïve T cells and deploy a screening platform for compound testing with the phenotypic characterization of iTregs.
For research use only. Not for use in diagnostic procedures.
Polarization of naïve CD4+ T cells to induced regulatory T cells for compound screening